Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Trazimera 150mg


To avoid
Risk of oligohydramnios and fatal pulmonary hypoplasia in the fetus

Contraindicated
Trazimera 150mg :
Type Medicine Authorised
Originator Biotech (Trazimera 150mg)
Agent Food & Drug Corporation
Distributor Food & Drug Corporation
Laboratory Pfizer
Responsible Party Pfizer Canada ULC
Origin Canada
Manufacturer Pfizer Manufacturing Belgium NV
Origin Belgium
ATC L01XC03

Your comment will appear shortly after approval

Trazimera 150mg :

Revision Date : 28/01/2022


Effect Frequency
Abdominal pain Very Common
Acne Common
Acute pulmonary oedema Not known
Acute respiratory distress syndrome Not known
Alopecia Very Common
Anaemia Very Common
Anaphylactic reactions Rare
Anaphylactic shock Rare
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Anorexia Very Common
Anxiety Common
Arrhythmia Very Common
Arthralgia (Pain joint) (Joint ache) Very Common
Arthritis Common
Asthenia Very Common
Asthma Common
Autoimmune thrombocytopenia Not known
Back pain Common
Blood pressure decreased Very Common
Blood pressure increased Very Common
Bone pain Common
Bronchospasm Not known
Cardiac flutter Very Common
Cardiogenic shock Not known
Cardiomyopathy Common
Chest pain Very Common
Chills Very Common
Congestive cardiac failure aggravated Common
Conjunctivitis Very Common
Constipation Very Common
Contusion Common
Cough Very Common
Cystitis Common
Deafness Uncommon
Depression Common
Dermatitis Common
Diarrhoea (Diarrhea) Very Common
Dizziness Very Common
Dry eye Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Very Common
Dyspnoea (dyspnea) Very Common
Ecchymosis Common
Ejection fraction decreased Very Common
Epistaxis (Nasal bleeding) Very Common
Erythema Very Common
Fatigue Very Common
Febrile neutropenia (Neutropenic fever) Very Common
Gallop rhythm present Not known
Glomerulonephritis membranous Not known
Glomerulonephropathy Not known
Haemorrhoids Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Very Common
Headache Very Common
Hepatitis Common
Hepatocellular injury Common
Hot flush Very Common
Hyperhidrosis Common
Hyperkalaemia Not known
Hypersensitivity Common
Hypertonia Common
Hypoprothrombinaemia Not known
Hypotension Common
Hypoxia Not known
Infection Very Common
Influenza Common
Influenza-like symptoms Very Common
Infusion related reaction Very Common
Insomnia Very Common
Interstitial lung disease Not known
Jaundice Rare
Lacrimation increased (Epiphora) Very Common
Laryngeal oedema Not known
Leucopenia (Leukopenia) Very Common
Lip swelling Very Common
Liver tenderness Common
Lung disorder Common
Lung infiltration (pulmonary infiltration) Not known
Maculopapular rash Common
Malaise Common
Malignant neoplasm progression Not known
Mastitis (breast inflammation) Common
Mucosal inflammation Very Common
Muscle spasms Common
Muscle tightness Very Common
Myalgia Very Common
Nail disorders Very Common
Nasopharyngitis Very Common
Neck pain Common
Neoplasm progression Not known
Neutropenic sepsis Common
Oedema Common
Oedema peripheral Very Common
Oligohydramnios Not known
Onychoclasis Common
Orthopnoea Not known
Oxygen saturation decreased Not known
Pain Very Common
Pain in extremity (Pain in limb) Common
Palpitations Common
Papilloedema Not known
Paraesthesia (paresthesia) Very Common
Pericardial effusion Uncommon
Peripheral neuropathy aggravated Common
Pharyngitis Common
Pleural effusion Common
Pneumonia Common
Pneumonitis Uncommon
Pruritus Common
Pulmonary fibrosis Not known
Pulmonary hypoplasia Not known
Pulmonary oedema Not known
Pyrexia Very Common
Renal disorder Common
Renal failure Not known
Renal hypoplasia Not known
Respiratory distress Not known
Respiratory failure Not known
Retinal haemorrhage Not known
Rhinitis Common
Rhinorrhoea Very Common
Sinusitis Common
Skin infection Common
Skin rash Very Common
Somnolence Common
Stomatitis Very Common
Supraventricular tachyarrhythmia Common
Swelling face Very Common
Thrombocytopenia (Thrombopenia) Very Common
Tremor Very Common
Tumour lysis syndrome Not known
Upper respiratory tract infection Common
Urinary tract infection Common
Urticaria Uncommon
Vasodilation Common
Vomiting Very Common
Weight decreased (Weight loss) Very Common
Wheezing Uncommon
White blood cell count decreased Very Common

Different Units By MoH Code

Revision Date : 28/01/2022

Revision Date : 28/01/2022

Trazimera 150mg  MoH 10211 :
Form Powder for concentrate for solution for infusion
Packaging Vial (Type I Glass)
Package Size Box of 1
Package Content 15 mL clear glass type I vial with butyl rubber stopper laminated with a fluoro-resin film
Strength 150mg
Storage Condition 2-8°C protect from light
Public Price 11962554,66 L.L.
Stratum D
NSSF ✘
Quarantine ✘
Reg. Number 38120/1
Submission date 11/03/2020
Registration Year 23/07/2020


Price Comparison

● Country: Finland
● Package Size: 150mg
● Public Price: 849.66 EUR ( 15,616,793.28 LBP )
● Pack size unit used: 1
● Cost/Unit: 849,66 EUR ( 15,604,662.45 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Germany
● Package Size: 1
● Public Price: 766.96 EUR ( 14,096,763.15 LBP )
● Pack size unit used: 1
● Cost/Unit: 766,96 EUR ( 14,079,118.30 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 1 stk.
● Public Price: 5197.45 DKK ( 12,790,768.53 LBP )
● Pack size unit used: 1
● Cost/Unit: 5197,45 DKK ( 12,789,661.09 LBP )
● Pharmacy Price: 3859.21 DKK ( 9497400.0337 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 1
● Public Price: 109962 ISK ( 12,190,387.32 LBP )
● Pack size unit used: 1
● Cost/Unit: 109962 ISK ( 12,190,387.32 LBP )
● Pharmacy Price: 84415 ISK ( 9358246.9 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for concentrate for solution for infusion
● Package Size: Box of 1
● Public Price: 11962554.66 LBP ( 11,962,554.66 LBP )
● Pack size unit used: 1
● Cost/Unit: 11962554,66 LBP ( 11,962,554.00 LBP )
● Pricing Date: 10/01/2024

● Country: Norway
● Package Size: x150mg
● Public Price: 6169.5 NOK ( 10,674,900.77 LBP )
● Pack size unit used: 1
● Cost/Unit: 6169,5 NOK ( 10,674,035.63 LBP )
● Pharmacy Price: 4786.89 NOK ( 8282612.1603 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 1
● Public Price: 562.45 CHF ( 9,595,537.61 LBP )
● Pack size unit used: 1
● Cost/Unit: 562,45 CHF ( 9,587,860.50 LBP )
● Exfactory Price: 475.67 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Greece
● Package Size: 1
● Public Price: 406.06 EUR ( 7,463,403.10 LBP )
● Pack size unit used: 1
● Cost/Unit: 406,06 EUR ( 7,462,300.30 LBP )
● Exfactory Price: 343.1 EUR
● Pharmacy Price: 348.25 EUR ( 6400852.4125 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 1
● Public Price: 366.66 GBP ( 7,388,481.33 LBP )
● Pack size unit used: 1
● Cost/Unit: 366,66 GBP ( 7,375,181.82 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 345 EUR ( 6,341,117.25 LBP )
● Pack size unit used: 1
● Cost/Unit: 345 EUR ( 6,341,117.25 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1 vial de 15 ml
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info